Parkinnova Therapeutics

Violet Therapeutics

This company develops small molecule inhibitors for pharmaceutical researchers to treat neurodegenerative diseases, including Alzheimer’s and Parkinson’s.

Polku Therapeutics

This company develops small-molecule drugs to treat neurodegenerative disorders such as Parkinson's and Alzheimer's disease for patients and pharmaceutical partners.

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions including Alzheimer's, Parkinson's and progressive supranuclear palsy.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Polku Therapeutics Oy

This company develops small molecule therapies targeting neurodegenerative diseases for patients with conditions such as dementia, Parkinson's and traumatic brain injury.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Lysosomal Therapeutics

This biotechnology firm develops small-molecule therapies for patients with neurodegenerative conditions such as Parkinson's disease and other lysosomal storage disorders.